• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Immunopathol Pharmacol . Lymphocyte subsets as a predictor of severity and prognosis in COVID-19 patients

tetano

Editor, Senior Moderator
Int J Immunopathol Pharmacol


. Jan-Dec 2021;35:20587384211048567.
doi: 10.1177/20587384211048567.
Lymphocyte subsets as a predictor of severity and prognosis in COVID-19 patients


Peng Zhang[SUP] 1 2 [/SUP], Wei Du[SUP] 2 3 [/SUP], Ting Yang[SUP] 2 4 [/SUP], Lei Zhao[SUP] 2 5 [/SUP], Richeng Xiong[SUP] 2 6 [/SUP], Yongqiang Li[SUP] 2 3 [/SUP], Yan Geng[SUP] 2 7 [/SUP], Weizhong Lu[SUP] 2 8 [/SUP], Juan Zhou[SUP] 2 9 [/SUP]



Affiliations

Abstract

Background: Coronavirus disease 2019 (COVID-19) had become a worldwide health threat. Early prediction of the severity of COVID-19 patients was important for reducing death rate and controlling this disease.
Methods and materials: A total of 301 patients confirmed with COVID-19 in Wuhan from 8 February to 10 April 2020 were included. Clinical data were collected and analyzed. Diagnostic and prognostic utility of blood cell counts and lymphocyte subsets in COVID-19 patients were investigated. The receiver operator characteristic curve (ROC) was used in discriminating the mild and severe/critical cases.
Results: There were difference in blood cell counts and lymphocyte subsets among mild, severe and critical patients, which were also influenced by comorbidities and duration of disease. The area under the ROC of lymphocyte, CD3[SUP]+[/SUP] T cells, CD4[SUP]+[/SUP] T cells, and CD8[SUP]+[/SUP] T cells were 0.718, 0.721, 0.718, and 0.670, which were higher than that of other hematological parameters. The optimal threshold was 1205, 691, 402, and 177 per μl, respectively. Patients with higher counts of lymphocyte, CD3[SUP]+[/SUP] T cells, CD4[SUP]+[/SUP] T cells, or CD8[SUP]+[/SUP] T cells were correlated with shorter length of stay in hospital (p < 0.05). Multivariable Cox regression analysis showed disease severity, CD3[SUP]+[/SUP] T cells counts and time when the nucleic acid turned negative were independent risk factors for in-hospital death of COVID-19 patients (p < 0.05).
Conclusion: Blood cell counts and lymphocyte subsets correlated with severity of COVID-19.

Keywords: COVID-19; lymphocyte subsets; prognosis; risk factors; severity.
 
Back
Top Bottom